The UK Nuclear Decommissioning Authority (NDA) honoured five award winners earlier in January at its tenth supply chain event ...

Deer Park, Illinois Saturday, February 8, 2025, 17:00 Hrs [IST] Eton Pharmaceuticals, Inc, an innovative pharmaceu ...

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

Japanese drugmaker Astellas Pharma says it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor ...

Cytokinetics , Inc. (NASDAQ:CYTK), with a market capitalization of $5.65 billion, is approaching a pivotal moment in its journey to become a leading player in the cardiovascular therapeutics market.

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on delivering therapeutics through effective oral delivery, announced today that it has received revised regulatory guidance for LPCN ...

Ironwood Pharma begins apraglutide NDA filing to treat patients with short bowel syndrome: Boston Friday, January 31, 2025, 13:00 Hrs [IST] Ironwood Pharmaceuticals, Inc, a biotec ...

We plan to include the long-term extension data in our NDA submission ... Under Tammi’s leadership we have strong commercial capabilities to support the future success of apraglutide, if ...

The FDA communicated that it has applied a standard three-month extension from the original goal date of February 28, 2025. Eton believes it has fully addressed all questions from the FDA and there ...

Grabar Law Office is investigating claims on behalf of Aldeyra shareholders. The investigation concerns whether certain officers of Aldeyra have breached their fiduciary duties owed to the company.